Safety and Immunogenicity of Different Meningitis Vaccine Formulations in Adolescents and Young Adults
Public ClinicalTrials.gov record NCT01272180. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase 2, Observer Blinded, Controlled, Randomized Multi-Center Study in Adolescents and Young Adults to Evaluate Safety and Immunogenicity of Two Different rMenB With OMV + MenACWY Combination Vaccination Formulations
Study identification
- NCT ID
- NCT01272180
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Novartis Vaccines
- Industry
- Enrollment
- 484 participants
Conditions and interventions
Conditions
Interventions
- Meningococcal (groups A, C, W, Y) oligosaccharide diphtheria CRM-197 conjugate combined with meningococcal (group B) multicomponent recombinant vaccine + OMV. Biological
- Meningococcal (group B) multicomponent recombinant adsorbed vaccine plus OMV. Biological
- Meningococcal (groups A, C, W, and Y) oligosaccharide diphtheria CRM-197 conjugate vaccine. Biological
- Meningococcal (groups A, C, W, Y) oligosaccharide diphtheria CRM-197 conjugate combined with meningococcal (group B) multicomponent recombinant vaccine + qOMV. Biological
Biological
Eligibility (public fields only)
- Age range
- 10 Years to 25 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2011
- Primary completion
- Sep 30, 2011
- Completion
- Aug 31, 2012
- Last update posted
- Jun 15, 2020
2011 – 2012
United States locations
- U.S. sites
- 8
- U.S. states
- 5
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Alabama Clinical Therapeutics, 806 St. Vincent's Drive, Suite 615 | Birmingham | Alabama | 35205 | — |
| Madera Family Medical Group,1111 West 4th Street | Madera | California | 93637 | — |
| Center for Clinical Trials LLC, 16660 Paramount Blvd, Suite 301 | Paramount | California | 90723 | — |
| Kentucky Pediatric/Adult Research, 201 south 5th street | Bardstown | Kentucky | 40004 | — |
| Bluegrass Clinical Research Inc.5512 Bardstown Road, Suite 2 | Louisville | Kentucky | 40291 | — |
| Ohio Pediatric Research Association, 7371 Brandt Pike, Suite C | Huber Heights | Ohio | 45424 | — |
| Ohio Pediatric Research Association, 1775 Delco Park Drive | Kettering | Ohio | 45420 | — |
| Focus Research Group,201 Signature Place | Lebanon | Tennessee | 37087 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01272180, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 15, 2020 · Synced Jun 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01272180 live on ClinicalTrials.gov.